LONDON, Aug. 13 -- Headache patients receiving prophylactic high-dose verapamil(Drug information on verapamil) face a risk of heart rhythm disturbances that warrants EKG monitoring of all patients on the therapy, investigators have concluded.
Arrhythmias occurred in 19% of patients with cluster headache receiving prophylactic doses of verapamil as high as 1200 mg a day, Peter J. Goadsby, M.D., Ph.D., D.Sc, of the Institute of Neurology here, and colleagues, reported in the August issue of Neurology.
Additionally, they said, 36% of patients had episodes of bradycardia.
"This study highlights the need for careful EKG monitoring of patients with [cluster headache] while on verapamil," the authors concluded. "EKG abnormalities could occur even at the lower doses of 240 mg daily, so it would be insufficient only to perform EKGs at higher doses."
